Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|March 11, 2009
Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureusClaudette Muller-Serieys, Azzam Saleh Mghir, Laurent Massias, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2011
Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureusAzzam Saleh-Mghir, Claudette Muller-Serieys, Aurélien Dinh, et al.
The Lancet. Microbe|July 22, 2026
mRNA vaccines for multidrug-resistant bacteria: promise, challenges, and microbiome-informed strategiesBenjamin Davido, Paul Loubet, Azzam Saleh-Mghir, et al.
Antibiotics (Basel, Switzerland)|May 24, 2024
Efficacy of Expired Antibiotics: A Real Debate in the Context of Repeated Drug ShortagesBenjamin Davido, Hugues Michelon, Christel Mamona, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Teicoplanin-containing cement spacers for treatment of experimental Staphylococcus aureus joint prosthesis infectionFarid Ismael, Rémy Bléton, Azzam Saleh-Mghir, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2014
Ceftaroline-Fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection modelLaure Gatin, Azzam Saleh-Mghir, Jason Tasse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2002
Evaluation of (99m)Tc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infectionLaure Sarda, Azzam Saleh-Mghir, Can Peker, et al.
Frontiers in Immunology|June 10, 2024
Normalization of eosinophil count is predictive of oxygen weaning over the course of COVID-19 infection among hospitalized adults during the first wave of 2020 pandemicBenjamin Davido, Karim Jaffal, Azzam Saleh-Mghir, et al.
The Journal of Antimicrobial Chemotherapy|March 10, 2023
Efficacy of ceftazidime/avibactam in various combinations for the treatment of experimental osteomyelitis in rabbits caused by OXA-48-/ESBL-producing Escherichia coliBenjamin Davido, Anne-Claude Crémieux, Isabelle Vaugier, et al.
International Journal of Antimicrobial Agents|December 8, 2022
Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniaeBenjamin Davido, Anne-Claude Crémieux, Isabelle Vaugier, et al.
Pageof 3